Long-term safety and efficacy of prolonged-release fampridine in Japanese patients with multiple sclerosis (MS): Results from the motion Japan Part b study

被引：0

作者：

Saida, T. ^{[1
]}

Yokoyama, K. ^{[2
]}

Masaki, K. ^{[3
]}

Ling, Y. ^{[4
]}

McNeill, M. ^{[5
]}

Lima, G. ^{[6
]}

机构：

[1] Kyoto Min Iren Cent Hosp, Kansai Multiple Sclerosis Ctr, Kyoto, Japan

[2] Juntendo Univ, Sch Med, Dept Neurol, Tokyo, Japan

[3] Kyushu Univ, Dept Neurol, Fukuoka, Japan

[4] Biogen, Clin Dev, Tokyo, Japan

[5] Biogen, Biostat, Maidenhead, Berks, England

[6] Biogen, Clin Dev, Cambridge, MA USA

来源：

关键词：

D O I：

10.1016/j.jns.2017.08.2200

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

2169

引用

页码：779 / 780

页数：2